30 May 2017 | 5:27 AM
 

Aurobindo Pharma Ltd. Share Price Live (BSE)
0

BSE Code: 524804 | NSE Symbol: AUROPHARMA
513.71
-19.55
(-3.66 %)
29 May 2017 | 03:55 PM
Change company
  • Open (Rs)
    535.00
  • Prev. close (Rs.)
    533.25
  • High (Rs.)
    544.50
  • Low (Rs.)
    504.00
  • 52W H (Rs.)
    895.00
  • 52W L (Rs.)
    504.00
  • Volume (Rs.)
    572462
  • MCap (Rs in Cr.)
    30,096.76
514
-21.80
(-4.07 %)
  • Open (Rs)
    537.40
  • High (Rs)
    547.05
  • Low (Rs)
    506.00
  • Prev. close(Rs)
    535.80
  • Contracts Tra.
    1,02,50,800
  • Turnover (Cr.)
    537
  • Open Interest
    1,71,47,900
  • Open Int. chg
    10,28,300.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
53.97
Operating Margin (%)
21.15
Gross Profit Margin (%)
18.40
Net Profit Margin (%)
13.00
Total Debt/Equity
0.75
Dividend payout Ratio (Net Profit)
9.92
Earning Retention Ratio
90.06

News

23 May 2017 - 12:11:00-Shares of Aurobindo Pharma tumbled over 6 per cent hitting 52-week low on the Bombay stock Exchange ...
30 Mar 2017 - 16:16:00-Pharma major Aurobindo Pharma Ltd on Thursday said it has received final nod from the US health regu...
30 Mar 2017 - 12:15:00-Shares of Aurobindo Pharma advanced over 1 per cent on the Bombay Stock Exchange after the drug make...
28 Mar 2017 - 17:34:00-Pharma major Aurobindo Pharma Ltd on Tuesday said it has received final nod from the US health regul...

Announcements

29-May-2017
Aurobindo Pharma - Board approves Dividend
29-May-2017
Aurobindo Pharma - Financial Results For The Quarter And Year Ended 31St March 2017
29-May-2017
Aurobindo Pharma - Outcome of Board Meeting
29-May-2017
Aurobindo Pharma - Second Interim Dividend For The Year 2016-17 & Record Date.
29-May-2017
Aurobindo Pharma - Updates

Religare Research

29 May 2017 | 06:40 PM
Gold futures ended the week in positive, despite a rise in investor expectations that Federal Reserv...
29 May 2017 | 05:44 PM
Tech Stars, comprises our 2 top stock picks filtered on the basis of momentum from our coverage univ...
29 May 2017 | 03:06 PM
Century Plyboards (I) Ltd.’s Q4FY17 result was inline with our estimates. The company reported 9% yo...
29 May 2017 | 02:25 PM
Swaraj Engines Ltd (SEL) reported healthy set of numbers for Q4FY17 with 41% YoY growth in net reven...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
94,96,996 715.12 53.27 -1.18
94,96,996 715.12 567.41 -1.18
94,96,996 715.12 586.84 -1.17
94,96,996 715.12 55.59 -1.17
48,31,294 363.80 429.70 -0.66

Shareholding Pattern

       
Promotors51.87%
Mutual Funds/UTI12.11%
FI/Banks0.65%
Insurance0.65%
FII20.99%
Government0.00%
Others4.63%

Peer Group

Company Intraday Graph
 Piramal Enterprises Ltd.
2,647.05(-2.79)
3356
 Dr. Reddy`s Laboratories Ltd.
2,424.85(0.55)
3294
 GlaxoSmithKline Pharmaceuticals Ltd.
2,325.05(-1.77)
3317
 Alkem Laboratories Ltd.
1,814.50(-2.77)
17141

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Aurobindo Pharma Ltd.-83.05-163.50-226.45
NIFTY(S&P CNX)291.10725.301,462.75
BSE SENSEX1,188.102,365.964,715.27
BSE 500105.44935.152,035.99

Corporate Details

Key Personal
Avnit Bimal Singh
Non Exe. & Ind. Director
D Rajagopala Reddy
Non Exe. & Ind. Director
K Nithyananda Reddy
Vice Chairman & Whole Time Dir
Key Address
Registered Office
Plot No. 2 Maitrivihar Ameerpet,Hyderabad,Telangana

Tel:040-23736370, Fax:040-23747340

info@aurobindo.com
http://www.aurobindo.com
Registrar Office
Karvy Computershare Private Ltd.
Add. :Karvy House 46 Avenue 4 Street No. 1 Banjara Hills

Make smart investment decisions with Star Ratings, a stock selection tool, based upon fundamental, technical and analyst recommendations. Star Ratings provides stock trading tips for Aurobindo Pharma Ltd. that will help you decide whether to buy, sell or hold Aurobindo Pharma Ltd. It also provides you with switch proposals on alternative stocks, i.e., which stocks to buy against Aurobindo Pharma Ltd.